Europe’s last manufacturer of ingredients for some vital antibiotics is closing its biggest domestic factory and shifting some production to China, dealing a blow to Brussels’ efforts to reduce drug dependence on Asia.
Lossmaking Xellia Pharmaceuticals said it could only survive against Chinese competition by moving many of its products to its plant there.
您已阅读14%（531字），剩余86%（3255字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。